RxDoctor Payments Data

Bradley Todd, PA

Physician Assistant · Saginaw, MINPI 1134665011

Payments from drug & device makers

$1,686in general payments, 2019–2025

Across 93 payments — averaging $18.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$174
  • AbbVie$173
  • AstraZeneca$152
  • GSK$131
  • Pfizer$120
  • Novo Nordisk$106
  • plus $830 from 22 others

What the payments were for

  • Food & beverage$1,65598%
  • Education$312%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,686 in reported general payments places this provider in the 80th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Medicare billing

Part B allowed, 2024
$198
Medicare patients
17
Services billed
29

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide95$105,925
JardianceEmpagliflozin74$93,518
TrulicityDulaglutide75$86,221
Trelegy ElliptaFluticasone/Umeclidin/Vilanter58$52,458
JanuviaSitagliptin Phosphate42$45,678
FarxigaDapagliflozin Propanediol43$44,553
Breztri AerosphereBudesonide/Glycopyr/Formoterol37$37,864
EliquisApixaban35$22,715
LinzessLinaclotide20$18,916
Spiriva HandihalerTiotropium Bromide26$18,275
GemtesaVibegron23$17,449
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog17$12,594
SymbicortBudesonide/Formoterol Fumarate28$8,770
Isosorbide Dinitrate11$6,529
ShingrixVaricella-Zoster Ge/As01b/Pf23$4,561

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$106$105,92595 claims
Boehringer IngelheimJardiance$90$93,51874 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$152$91,187108 claims
Lilly USA, LLCTrulicity$28$86,22175 claims
GSKTrelegy Ellipta, Shingrix$131$57,01981 claims
PfizerEliquis$120$22,71535 claims
AbbVieLinzess$173$18,91620 claims
Sumitomo Pharma America, Inc.Gemtesa$50$17,44923 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Saginaw

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →